Neurological Sciences

, Volume 34, Issue 5, pp 613–619 | Cite as

Gray matter atrophy in Parkinson’s disease with dementia: evidence from meta-analysis of voxel-based morphometry studies

  • Ping Lei Pan
  • Hai Cun Shi
  • Jian Guo Zhong
  • Pei Rong Xiao
  • Yuan Shen
  • Li Juan Wu
  • Yuan Ying Song
  • Gui Xiang He
  • Hua Liang Li
Review Article

Abstract

Voxel-based morphometry (VBM) studies have provided cumulative evidence of gray matter (GM) atrophy in patients with Parkinson’s disease with dementia (PDD) relative to healthy controls (HC). However, not all the studies reported entirely consistent findings. A systematic search for VBM studies of PDD patients and HC subjects published in PubMed and Embase databases from January 2000 to June 2012 was conducted. Meta-analysis was performed by using a newly improved voxel-based meta-analytic technique, effect size signed differential mapping, to quantitatively explore the GM abnormalities between PDD patients and HC subjects. A total of 6 cross-sectional VBM studies involving 105 PDD patients and 131 HC subjects met the inclusion criteria. Considerable regional GM decrease was detected in the medial temporal lobe (MTL) and basal ganglia. The findings of the present study remained largely unchanged in the entire brain jackknife sensitivity analyses. Meta-regression showed dementia severity correlated with the left MTL. The present meta-analysis provided evidence of PDD-related GM atrophy, which suggested MTL and basal ganglia were implicated in PDD. This finding could give us further insight about the pathophysiological basis revealed by structure abnormalities in PDD.

Keywords

Voxel-based morphometry Parkinson’s disease with dementia Signed differential mapping Gray matter Meta-analysis Medial temporal lobe 

References

  1. 1.
    Emre M, Aarsland D, Brown R, Burn DJ, Duyckaerts C, Mizuno Y, Broe GA, Cummings J, Dickson DW, Gauthier S, Goldman J, Goetz C, Korczyn A, Lees A, Levy R, Litvan I, McKeith I, Olanow W, Poewe W, Quinn N, Sampaio C, Tolosa E, Dubois B (2007) Clinical diagnostic criteria for dementia associated with Parkinson’s disease. Mov Disord 22(12):1689–1707. doi:10.1002/mds.21507 quiz 1837PubMedCrossRefGoogle Scholar
  2. 2.
    Aarsland D, Andersen K, Larsen JP, Lolk A, Kragh-Sorensen P (2003) Prevalence and characteristics of dementia in Parkinson disease: an 8-year prospective study. Arch Neurol 60(3):387–392PubMedCrossRefGoogle Scholar
  3. 3.
    Emre M (2003) Dementia associated with Parkinson’s disease. Lancet Neurol 2(4):229–237PubMedCrossRefGoogle Scholar
  4. 4.
    Mattila PM, Roytta M, Torikka H, Dickson DW, Rinne JO (1998) Cortical Lewy bodies and Alzheimer-type changes in patients with Parkinson’s disease. Acta Neuropathol 95(6):576–582PubMedCrossRefGoogle Scholar
  5. 5.
    Camicioli R, Moore MM, Kinney A, Corbridge E, Glassberg K, Kaye JA (2003) Parkinson’s disease is associated with hippocampal atrophy. Mov Disord 18(7):784–790. doi:10.1002/mds.10444 PubMedCrossRefGoogle Scholar
  6. 6.
    Bouchard TP, Malykhin N, Martin WR, Hanstock CC, Emery DJ, Fisher NJ, Camicioli RM (2008) Age and dementia-associated atrophy predominates in the hippocampal head and amygdala in Parkinson’s disease. Neurobiol Aging 29(7):1027–1039. doi:10.1016/j.neurobiolaging.2007.02.002 PubMedCrossRefGoogle Scholar
  7. 7.
    Junque C, Ramirez-Ruiz B, Tolosa E, Summerfield C, Marti MJ, Pastor P, Gomez-Anson B, Mercader JM (2005) Amygdalar and hippocampal MRI volumetric reductions in Parkinson’s disease with dementia. Mov Disord 20(5):540–544. doi:10.1002/mds.20371 PubMedCrossRefGoogle Scholar
  8. 8.
    Kenny ER, Burton EJ, O’Brien JT (2008) A volumetric magnetic resonance imaging study of ento rhinal cortex volume in dementia with Lewy bodies. A comparison with Alzheimer’s disease and Parkinson’s disease with and without dementia. Dement Geriatr Cogn Disord 26(3):218–225. doi:10.1159/000153432 PubMedCrossRefGoogle Scholar
  9. 9.
    Tam CW, Burton EJ, McKeith IG, Burn DJ, O’Brien JT (2005) Temporal lobe atrophy on MRI in Parkinson disease with dementia: a comparison with Alzheimer disease and dementia with Lewy bodies. Neurology 64(5):861–865. doi:10.1212/01.wnl.0000153070.82309.d4 PubMedCrossRefGoogle Scholar
  10. 10.
    Apostolova LG, Beyer M, Green AE, Hwang KS, Morra JH, Chou YY, Avedissian C, Aarsland D, Janvin CC, Larsen JP, Cummings JL, Thompson PM (2010) Hippocampal, caudate, and ventricular changes in Parkinson’s disease with and without dementia. Mov Disord 25(6):687–695. doi:10.1002/mds.22799 PubMedCrossRefGoogle Scholar
  11. 11.
    Camicioli R, Sabino J, Gee M, Bouchard T, Fisher N, Hanstock C, Emery D, Martin WR (2011) Ventricular dilatation and brain atrophy in patients with Parkinson’s disease with incipient dementia. Mov Disord 26(8):1443–1450. doi:10.1002/mds.23700 PubMedCrossRefGoogle Scholar
  12. 12.
    Beyer MK, Janvin CC, Larsen JP, Aarsland D (2007) A magnetic resonance imaging study of patients with Parkinson’s disease with mild cognitive impairment and dementia using voxel-based morphometry. J Neurol Neurosurg Psychiatry 78(3):254–259. doi:10.1136/jnnp.2006.093849 PubMedCrossRefGoogle Scholar
  13. 13.
    Burton EJ, McKeith IG, Burn DJ, Williams ED, O’Brien JT (2004) Cerebral atrophy in Parkinson’s disease with and without dementia: a comparison with Alzheimer’s disease, dementia with Lewy bodies and controls. Brain 127(Pt 4):791–800. doi:10.1093/brain/awh088 PubMedCrossRefGoogle Scholar
  14. 14.
    Summerfield C, Junque C, Tolosa E, Salgado-Pineda P, Gomez-Anson B, Marti MJ, Pastor P, Ramirez-Ruiz B, Mercader J (2005) Structural brain changes in Parkinson disease with dementia: a voxel-based morphometry study. Arch Neurol 62(2):281–285. doi:10.1001/archneur.62.2.281 PubMedCrossRefGoogle Scholar
  15. 15.
    Melzer TR, Watts R, MacAskill MR, Pitcher TL, Livingston L, Keenan RJ, Dalrymple-Alford JC, Anderson TJ (2012) Grey matter atrophy in cognitively impaired Parkinson’s disease. J Neurol Neurosurg Psychiatry 83(2):188–194. doi:10.1136/jnnp-2011-300828 PubMedCrossRefGoogle Scholar
  16. 16.
    Compta Y, Ibarretxe-Bilbao N, Pereira JB, Junque C, Bargallo N, Tolosa E, Valldeoriola F, Munoz E, Camara A, Buongiorno M, Marti MJ (2012) Grey matter volume correlates of cerebrospinal markers of Alzheimer-pathology in Parkinson’s disease and related dementia. Parkinsonism Relat Disord. doi:10.1016/j.parkreldis.2012.04.028
  17. 17.
    Sanchez-Castaneda C, Rene R, Ramirez-Ruiz B, Campdelacreu J, Gascon J, Falcon C, Calopa M, Jauma S, Juncadella M, Junque C (2009) Correlations between gray matter reductions and cognitive deficits in dementia with Lewy Bodies and Parkinson’s disease with dementia. Mov Disord 24(12):1740–1746. doi:10.1002/mds.22488 PubMedCrossRefGoogle Scholar
  18. 18.
    Lee JE, Park B, Song SK, Sohn YH, Park HJ, Lee PH (2010) A comparison of gray and white matter density in patients with Parkinson’s disease dementia and dementia with Lewy bodies using voxel-based morphometry. Mov Disord 25(1):28–34. doi:10.1002/mds.22858 PubMedCrossRefGoogle Scholar
  19. 19.
    Song SK, Lee JE, Park HJ, Sohn YH, Lee JD, Lee PH (2011) The pattern of cortical atrophy in patients with Parkinson’s disease according to cognitive status. Mov Disord 26(2):289–296. doi:10.1002/mds.23477 PubMedCrossRefGoogle Scholar
  20. 20.
    Ibarretxe-Bilbao N, Ramirez-Ruiz B, Tolosa E, Marti MJ, Valldeoriola F, Bargallo N, Junque C (2008) Hippocampal head atrophy predominance in Parkinson’s disease with hallucinations and with dementia. J Neurol 255(9):1324–1331. doi:10.1007/s00415-008-0885-8 PubMedCrossRefGoogle Scholar
  21. 21.
    Radua J, Mataix-Cols D (2009) Voxel-wise meta-analysis of grey matter changes in obsessive-compulsive disorder. The British Journal of Psychiatry 195(5):393–402. doi:10.1192/bjp.bp.108.055046 PubMedCrossRefGoogle Scholar
  22. 22.
    Radua J, Mataix-Cols D, Phillips ML, El-Hage W, Kronhaus DM, Cardoner N, Surguladze S (2011) A new meta-analytic method for neuroimaging studies that combines reported peak coordinates and statistical parametric maps. Eur Psychiatry. doi:10.1016/j.eurpsy.2011.04.001
  23. 23.
    Li J, Pan P, Huang R, Shang H (2012) A meta-analysis of voxel-based morphometry studies of white matter volume alterations in Alzheimer’s disease. Neurosci Biobehav Rev 36(2):757–763. doi:10.1016/j.neubiorev.2011.12.001 PubMedCrossRefGoogle Scholar
  24. 24.
    Pan PL, Song W, Shang HF (2012) Voxel-wise meta-analysis of gray matter abnormalities in idiopathic Parkinson’s disease. Eur J Neurol 19(2):199–206. doi:10.1111/j.1468-1331.2011.03474.x PubMedCrossRefGoogle Scholar
  25. 25.
    Via E, Radua J, Cardoner N, Happe F, Mataix-Cols D (2011) Meta-analysis of gray matter abnormalities in autism spectrum disorder: should Asperger disorder be subsumed under a broader umbrella of autistic spectrum disorder? Arch Gen Psychiatry 68(4):409–418. doi:10.1001/archgenpsychiatry.2011.27 PubMedCrossRefGoogle Scholar
  26. 26.
    Li J, Pan P, Song W, Huang R, Chen K, Shang H (2011) A meta-analysis of diffusion tensor imaging studies in amyotrophic lateral sclerosis. Neurobiol Aging. doi:10.1016/j.neurobiolaging.2011.04.007 Google Scholar
  27. 27.
    Bora E, Fornito A, Yucel M, Pantelis C (2010) Voxelwise meta-analysis of gray matter abnormalities in bipolar disorder. Biol Psychiatry 67(11):1097–1105. doi:10.1016/j.biopsych.2010.01.020 PubMedCrossRefGoogle Scholar
  28. 28.
    Pan P, Song W, Yang J, Huang R, Chen K, Gong QY, Zhong JG, Shi HC, Shang HF (2012) Gray matter atrophy in behavioral variant frontotemporal dementia: a meta-analysis of voxel-based morphometry studies. Dement Geriatr Cogn Disord 33(2–3):141–148PubMedCrossRefGoogle Scholar
  29. 29.
    Radua J, Mataix-Cols D (2009) Voxel-wise meta-analysis of grey matter changes in obsessive-compulsive disorder. Br J Psychiatry 195(5):393–402. doi:10.1192/bjp.bp.108.055046 PubMedCrossRefGoogle Scholar
  30. 30.
    Radua J, Mataix-Cols D, Phillips ML, El-Hage W, Kronhaus DM, Cardoner N, Surguladze S (2011) A new meta-analytic method for neuroimaging studies that combines reported peak coordinates and statistical parametric maps. Eur Psychiatry. doi:10.1016/j.eurpsy.2011.04.001 PubMedGoogle Scholar
  31. 31.
    Richlan F, Kronbichler M, Wimmer H (2012) Structural abnormalities in the dyslexic brain: A meta-analysis of voxel-based morphometry studies. Hum Brain Mapp. doi:10.1002/hbm.22127
  32. 32.
    Jeneson A, Squire LR (2012) Working memory, long-term memory, and medial temporal lobe function. Learn Mem 19(1):15–25. doi:10.1101/lm.024018.111 PubMedCrossRefGoogle Scholar
  33. 33.
    Barense MD, Bussey TJ, Lee AC, Rogers TT, Davies RR, Saksida LM, Murray EA, Graham KS (2005) Functional specialization in the human medial temporal lobe. J Neurosci 25(44):10239–10246. doi:10.1523/jneurosci.2704-05.2005 PubMedCrossRefGoogle Scholar
  34. 34.
    Gabrieli JD, Brewer JB, Poldrack RA (1998) Images of medial temporal lobe functions in human learning and memory. Neurobiol Learn Mem 70(1–2):275–283. doi:10.1006/nlme.1998.3853 PubMedCrossRefGoogle Scholar
  35. 35.
    Scoville WB, Milner B (1957) Loss of recent memory after bilateral hippocampal lesions. J Neurol Neurosurg Psychiatry 20(1):11–21PubMedCrossRefGoogle Scholar
  36. 36.
    Yang TT, Menon V, Eliez S, Blasey C, White CD, Reid AJ, Gotlib IH, Reiss AL (2002) Amygdalar activation associated with positive and negative facial expressions. NeuroReport 13(14):1737–1741PubMedCrossRefGoogle Scholar
  37. 37.
    Kraybill ML, Larson EB, Tsuang DW, Teri L, McCormick WC, Bowen JD, Kukull WA, Leverenz JB, Cherrier MM (2005) Cognitive differences in dementia patients with autopsy-verified AD, Lewy body pathology, or both. Neurology 64(12):2069–2073. doi:10.1212/01.wnl.0000165987.89198.65 PubMedCrossRefGoogle Scholar
  38. 38.
    Mattila PM, Rinne JO, Helenius H, Roytta M (1999) Neuritic degeneration in the hippocampus and amygdala in Parkinson’s disease in relation to Alzheimer pathology. Acta Neuropathol 98(2):157–164PubMedCrossRefGoogle Scholar
  39. 39.
    Yang J, Pan P, Song W, Huang R, Li J, Chen K, Gong Q, Zhong J, Shi H, Shang H (2012) Voxelwise meta-analysis of gray matter anomalies in Alzheimer’s disease and mild cognitive impairment using anatomic likelihood estimation. J Neurol Sci 316(1–2):21–29. doi:10.1016/j.jns.2012.02.010 PubMedCrossRefGoogle Scholar
  40. 40.
    Haber SN (2003) The primate basal ganglia: parallel and integrative networks. J Chem Neuroanat 26(4):317–330PubMedCrossRefGoogle Scholar
  41. 41.
    Graybiel AM (1995) The basal ganglia. Trends Neurosci 18(2):60–62PubMedCrossRefGoogle Scholar
  42. 42.
    Kalaitzakis ME, Walls AJ, Pearce RK, Gentleman SM (2011) Striatal Abeta peptide deposition mirrors dementia and differentiates DLB and PDD from other parkinsonian syndromes. Neurobiol Dis 41(2):377–384. doi:10.1016/j.nbd.2010.10.005 PubMedCrossRefGoogle Scholar
  43. 43.
    Kalaitzakis ME, Graeber MB, Gentleman SM, Pearce RK (2008) Striatal beta-amyloid deposition in Parkinson disease with dementia. J Neuropathol Exp Neurol 67(2):155–161. doi:10.1097/NEN.0b013e31816362aa PubMedCrossRefGoogle Scholar
  44. 44.
    Jellinger KA, Attems J (2006) Does striatal pathology distinguish Parkinson disease with dementia and dementia with Lewy bodies? Acta Neuropathol 112(3):253–260. doi:10.1007/s00401-006-0088-2 PubMedCrossRefGoogle Scholar
  45. 45.
    Beyer MK, Aarsland D (2008) Grey matter atrophy in early versus late dementia in Parkinson’s disease. Parkinsonism Relat Disord 14(8):620–625. doi:10.1016/j.parkreldis.2008.01.021 PubMedCrossRefGoogle Scholar
  46. 46.
    Kehagia AA, Barker RA, Robbins TW (2010) Neuropsychological and clinical heterogeneity of cognitive impairment and dementia in patients with Parkinson’s disease. Lancet Neurol 9(12):1200–1213. doi:10.1016/s1474-4422(10)70212-x PubMedCrossRefGoogle Scholar
  47. 47.
    McKeith IG, Dickson DW, Lowe J, Emre M, O’Brien JT, Feldman H, Cummings J, Duda JE, Lippa C, Perry EK, Aarsland D, Arai H, Ballard CG, Boeve B, Burn DJ, Costa D, Del Ser T, Dubois B, Galasko D, Gauthier S, Goetz CG, Gomez-Tortosa E, Halliday G, Hansen LA, Hardy J, Iwatsubo T, Kalaria RN, Kaufer D, Kenny RA, Korczyn A, Kosaka K, Lee VM, Lees A, Litvan I, Londos E, Lopez OL, Minoshima S, Mizuno Y, Molina JA, Mukaetova-Ladinska EB, Pasquier F, Perry RH, Schulz JB, Trojanowski JQ, Yamada M (2005) Diagnosis and management of dementia with Lewy bodies: third report of the DLB Consortium. Neurology 65(12):1863–1872. doi:10.1212/01.wnl.0000187889.17253.b1 PubMedCrossRefGoogle Scholar
  48. 48.
    Aarsland D, Londos E, Ballard C (2009) Parkinson’s disease dementia and dementia with Lewy bodies: different aspects of one entity. Int Psychogeriatr 21(2):216–219. doi:10.1017/s1041610208008612 PubMedCrossRefGoogle Scholar
  49. 49.
    Aarsland D, Ballard CG, Halliday G (2004) Are Parkinson’s disease with dementia and dementia with Lewy bodies the same entity? J Geriatr Psychiatry Neurol 17(3):137–145. doi:10.1177/0891988704267470 PubMedCrossRefGoogle Scholar
  50. 50.
    Revuelta GJ, Lippa CF (2009) Dementia with Lewy bodies and Parkinson’s disease dementia may best be viewed as two distinct entities. Int Psychogeriatr 21(2):213–216. doi:10.1017/s1041610208008600 PubMedCrossRefGoogle Scholar
  51. 51.
    McKeith I (2009) Commentary: DLB and PDD: the same or different? Is there a debate? Int Psychogeriatr 21(2):220–224. doi:10.1017/s1041610208008624 PubMedCrossRefGoogle Scholar
  52. 52.
    Lippa CF, Duda JE, Grossman M, Hurtig HI, Aarsland D, Boeve BF, Brooks DJ, Dickson DW, Dubois B, Emre M, Fahn S, Farmer JM, Galasko D, Galvin JE, Goetz CG, Growdon JH, Gwinn-Hardy KA, Hardy J, Heutink P, Iwatsubo T, Kosaka K, Lee VM, Leverenz JB, Masliah E, McKeith IG, Nussbaum RL, Olanow CW, Ravina BM, Singleton AB, Tanner CM, Trojanowski JQ, Wszolek ZK (2007) DLB and PDD boundary issues: diagnosis, treatment, molecular pathology, and biomarkers. Neurology 68(11):812–819. doi:10.1212/01.wnl.0000256715.13907.d3 PubMedCrossRefGoogle Scholar
  53. 53.
    Beyer MK, Larsen JP, Aarsland D (2007) Gray matter atrophy in Parkinson disease with dementia and dementia with Lewy bodies. Neurology 69(8):747–754. doi:10.1212/01.wnl.0000269666.62598.1c PubMedCrossRefGoogle Scholar

Copyright information

© Springer-Verlag Italia 2012

Authors and Affiliations

  • Ping Lei Pan
    • 1
  • Hai Cun Shi
    • 1
  • Jian Guo Zhong
    • 1
  • Pei Rong Xiao
    • 1
  • Yuan Shen
    • 1
  • Li Juan Wu
    • 1
  • Yuan Ying Song
    • 1
  • Gui Xiang He
    • 1
  • Hua Liang Li
    • 1
  1. 1.Department of NeurologyYancheng Third People’s Hospital (The affiliated Yancheng hospital of Southeast University medical college)YanChengChina

Personalised recommendations